Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Pulmonary arterial hypertension: evaluation and management LaRaia AV; Waxman ABSouth Med J 2007[Apr]; 100 (4): 393-9Pulmonary arterial hypertension (PAH), a rare disease involving the pulmonary vascular circuit, is defined as an elevation in pulmonary arterial pressures and is characterized by symptoms of dyspnea, chest pain, and syncope. If left untreated, the disease carries a high mortality rate, with the most common cause of death being decompensated right heart failure. Over the past 5 years, there have been significant advances in this field in regards to understanding the pathogenesis, diagnosis, and classification of PAH. The availability of newer drugs has resulted in a radical change in the management of this disease with significant improvement in both quality of life and mortality. Ongoing research promises to lead to a more comprehensive understanding of the genetics, etiology, and pathogenesis of pulmonary arterial hypertension, which may ultimately translate into more effective therapeutic options.|*Hypertension, Pulmonary/mortality/physiopathology/therapy[MESH]|Antihypertensive Agents/*therapeutic use[MESH]|Calcium Channel Blockers/*therapeutic use[MESH]|Cardiac Surgical Procedures/*methods[MESH]|Disease Progression[MESH]|Drug Therapy, Combination[MESH]|Endothelin A Receptor Antagonists[MESH]|Humans[MESH]|Phosphodiesterase Inhibitors/*therapeutic use[MESH]|Prostaglandins/*therapeutic use[MESH]|Pulmonary Wedge Pressure/physiology[MESH]|Survival Rate[MESH]|Treatment Outcome[MESH] |